Serum IL-8 levels were found to be correlated with increasing stages of PCa and were useful to discriminate cancer from benign prostatic hyperplasia, suggesting that IL-8 serum assay could have a clinical value in daily practice [7]. The gene discussed is CXCL8; the disease is posterior cortical atrophy.